Clinical trial
Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD…
NCT00157235 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00157235 |
|---|---|
| Title | Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients |
| Official title | A Randomized, Double Blind , Placebo Controlled Trial to Compare the Effect of Tiotropium Inhalation Capsules on Exercise Tolerance in Patients With COPD Participating in 8 Weeks of Pulmonary Rehabilitation |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | Tiotropium bromide |
| Enrollment | 234 |
| Start date | Sep 1, 2002 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 28, 2017 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: